ResMedvs.Stryker
RMD vs SYK · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Stryker is about 3.3× larger than ResMed by market cap; ResMed trades at the lower P/E (21.1 vs 28.7); year to date, ResMed leads (−5.9% vs −21.2%).
Side by side
| RMD | SYK | |
|---|---|---|
| Market cap | $32.1B | $107B |
| Price | $230.05 | $277.33 |
| Today | +1.5% | +0.1% |
| Return YTD | −5.9% | −21.2% |
| Return 1Y | −19.7% | −26.2% |
| Since June 26, 2026 | +14.9% | −16.6% |
| P/E | 21.1 | 28.7 |
| P/S | 5.7 | 4.1 |
| P/B | 4.9 | 4.5 |
Data as of 2026-10-09 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
ResMedRMD
CPAP machines and masks for sleep apnea, sold with cloud software, next to a wider respiratory equipment range.
Full RMD profile →StrykerSYK
Orthopaedic implants and surgical equipment, with Mako bringing robot assistance into the operating room.
Full SYK profile →More RMD & SYK comparisons
Other head-to-heads in the Medtech & devices segment.